Dormant Cancer Cells: How to Erase Them
Study summary on breast-cancer dormancy, persistence, and the idea of targeting dormant cells
Last updated
Was this helpful?
Study summary on breast-cancer dormancy, persistence, and the idea of targeting dormant cells
This page is for the study summary on dormant cancer cells and the question of how they might be targeted or erased.
It should hold the main logic behind why dormancy matters in breast cancer and why this topic keeps returning in recurrence discussions.
Dormancy is now covered more fully in the cross-cancer section:
Use this breast-cancer page as a narrower pointer when a future study summary needs to focus on breast-specific dormancy issues.
For the endocrine-therapy angle in ER-positive disease, see Endocrine Therapy, Stable Disease, and Dormancy in ER-Positive Breast Cancer.
Dormancy is a cross-subtype issue.
It can matter in hormone-receptor-positive, HER2-positive, and triple-negative settings, even if the biology differs.
Use this page for:
what dormant cancer cells are
why they matter in recurrence and long-tail risk discussions
how researchers are thinking about eliminating or destabilising dormant cells
Last updated
Was this helpful?
Was this helpful?